Abstract
Poorer performance in tasks testing executive function (EF) is associated with a range of psychopathologies such as schizophrenia, major depressive disorder (MDD) and anxiety, as well as smoking and alcohol consumption. We used two-sample bidirectional Mendelian randomization to examine whether these may reflect causal relationships and the direction of causation. We used genome-wide association study summary data (N = 17 310 to 848 460) for a common EF factor score (cEF), schizophrenia, MDD, anxiety, smoking initiation, alcohol consumption, alcohol dependence and cannabis use disorder (CUD). We found evidence of increased cEF on reduced schizophrenia liability (OR = 0.10; CI: 0.05 to 0.19; p-value = 3.43 × 10-12), MDD liability (OR = 0.52; CI: 0.38 to 0.72; p-value = 5.23 × 10-05), drinks per week (β =-0.06; CI:-0.10 to-0.02; p-value = 0.003) and CUD liability (OR = 0.27; CI: 0.12 to 0.61; p-value = 1.58 × 10-03). We also found evidence of increased schizophrenia liability (β =-0.04; CI:-0.04 to-0.03; p-value = 3.25 × 10-27) and smoking initiation on decreased cEF (β =-0.06; CI:-0.09 to-0.03; p-value = 6.11 × 10-05). Our results indicate potential causal relationships between cEF and mental health and substance use. Further studies are required to improve our understanding of the underlying mechanisms of these effects, but our results suggest that EF may be a promising intervention target for mental health and substance use.
Original language | English |
---|---|
Article number | 220631 |
Journal | Royal Society Open Science |
Volume | 9 |
Issue number | 12 |
Early online date | 14 Dec 2022 |
DOIs | |
Publication status | Published - 14 Dec 2022 |
Data Availability Statement
The GWAS data for cEF will be made available on the GWAS catalogue and is currently available on request from the Friedman Lab at University of Colorado, Boulder ([email protected]). Once the paper associated with this GWAS has been published, the data will be made publicly available for download without restriction. Other GWAS data used in this study are publicly available GWAS data for schizophrenia (https://www.med.unc.edu/pgc/download-results/scz/), MDD (https://www.med.unc.edu/pgc/download-results/mdd/), anxiety (https://www.med.unc.edu/pgc/download-results/angst/?choice=Other+GWAS+DataAnxiety+Neuro+Genetics+Study+%28ANGST%29), alcohol dependence (https://figshare.com/articles/dataset/sud2018-alc/14672187) and CUD (https://figshare.com/articles/dataset/sud2020-cud/14842692). Finally, GWAS data for smoking initiation and drinks per week with UK Biobank and 23andMe removed can be found here: https://conservancy.umn.edu/handle/11299/201564. The full GWAS summary statistics for the 23andMe discovery data set (which we combined with the smoking initiation and drinks per week publicly available data) will be made available through 23andMe to qualified researchers under an agreement with 23andMe that protects the privacy of the 23andMe participants. Please visit https://research.23andme.com/collaborate/#dataset-access/ for more information and to apply to access the data. Code availability: The analysis code that forms the basis of the results presented here is available from the University of Bristol's Research Data Repository, data.bris, at https://doi.org/10.5523/bris.2ejxinnlt7kmr2hda2infx5r1k [48].The data are provided in the electronic supplementary material [49].
Acknowledgements
We thank all the contributors to the consortia we have used GWAS results from in our analyses. We would like to thank the research participants and employees of 23andMe for making this work possible.Funding
This work was supported by the UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol (grant ref: MC_UU_00011/7) and the NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. H.M.S. is supported by the European Research Council (grant ref: 758813 MHINT). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. A.S.H. acknowledges funding from that National Institute on Drug Abuse (grant ref: T32DA007261) and National Institute on Alcohol Abuse and Alcoholism (grant ref: AA030083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Keywords
- executive function
- Mendelian randomization
- mental health
- substance use
ASJC Scopus subject areas
- General